Aligos Therapeutics's total assets for Q1 2025 were $150.70M, an increase of 115.00% from the previous quarter. ALGS total liabilities were $34.25M for the fiscal quarter, a -65.42% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.